De Masi Alessandra, Scognamiglio Pasqualina Liana, Battista Edmondo, Netti Paolo Antonio, Causa Filippo
Center for Advanced Biomaterials for Healthcare@CRIB, Istituto Italiano di Tecnologia (IIT), Largo Barsanti e Matteucci 53, 80125 Naples, Italy.
Dipartimento di Ingegneria Chimica del Materiali e della Produzione Industriale (DICMAPI), University "Federico II", Piazzale Tecchio 80, 80125 Naples, Italy.
Lab Chip. 2023 May 16;23(10):2458-2468. doi: 10.1039/d2lc01080a.
Novel microparticles have generated growing interest in diagnostics for potential sensitivity and specificity in biomolecule detection and for the possibility to be integrated in a micro-system array as a lab-on-chip. Indeed, bead-based technologies integrated in microfluidics could speed up incubation steps, reduce reagent consumption and improve accessibility of diagnostic devices to non-expert users. To limit non-specific interactions with interfering molecules and to exploit the whole particle volume for bioconjugation, hydrogel microparticles, particularly polyethylene glycol-based, have emerged as promising materials to develop high-performing biosensors since their network can be functionalized to concentrate the target and improve detection. However, the limitations in positioning, trapping and mainly fine manipulation of a precise number of particles in microfluidics have largely impaired point-of-care applications. Herein, we developed an on-chip sandwich immunoassay for the detection of human immunoglobulin G in biological fluids. The detection system is based on finely engineered cleavable PEG-based microparticles, functionalized with specific monoclonal antibodies. By changing the particle number, we demonstrated tuneable specificity and sensitivity (down to 3 pM) in serum and urine. Therefore, a controlled number of hydrogel particles have been integrated in a microfluidic device for on-chip detection (HyPoC) allowing for their precise positioning and fluid exchange for incubation, washing and target detection. HyPoC dramatically decreases incubation time from 180 minutes to one minute and reduces washing volumes from 3.5 ml to 90 μL, achieving a limit of detection of 0.07 nM (with a dynamic range of 0.07-1 nM). Thus, the developed approach represents a versatile, fast and easy point-of-care testing platform for immunoassays.
新型微粒在生物分子检测的潜在灵敏度和特异性以及作为芯片实验室集成到微系统阵列中的可能性方面,引发了越来越多的关注。事实上,集成在微流控技术中的基于微珠的技术可以加快孵育步骤,减少试剂消耗,并提高诊断设备对非专业用户的可及性。为了限制与干扰分子的非特异性相互作用,并充分利用整个颗粒体积进行生物共轭,水凝胶微粒,特别是基于聚乙二醇的水凝胶微粒,已成为开发高性能生物传感器的有前途的材料,因为它们的网络可以功能化以富集目标并提高检测效果。然而,在微流控技术中对精确数量的微粒进行定位、捕获以及主要是精细操作方面的限制,在很大程度上阻碍了即时检测应用。在此,我们开发了一种用于检测生物流体中人类免疫球蛋白G的芯片夹心免疫测定法。该检测系统基于精心设计的可裂解聚乙二醇基微粒,用特异性单克隆抗体进行功能化。通过改变微粒数量,我们在血清和尿液中展示了可调节的特异性和灵敏度(低至3 pM)。因此,已将可控数量的水凝胶微粒集成到用于芯片检测(HyPoC)的微流控装置中,实现其精确定位以及用于孵育、洗涤和目标检测的流体交换。HyPoC将孵育时间从180分钟大幅缩短至1分钟,并将洗涤体积从3.5毫升减少至90微升,检测限达到0.07 nM(动态范围为0.07 - 1 nM)。因此,所开发的方法代表了一种用于免疫测定的通用、快速且简便的即时检测平台。